EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potentiation of BKCa channels by cystic fibrosis transmembrane conductance regulator correctors VX-445 and VX-121

Aaron Kolski-Andreaco, Stefanie Taiclet, Michael M Myerburg, John Sembrat, Robert J Bridges, Adam C Straub, Zachary P Wills, Michael B Butterworth, Daniel C Devor

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci176328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Aaron Kolski-Andreaco und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Large-Conductance Calcium-Activated Potassium Channel alpha Subunits, Benzodioxoles. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystic fibrosis results from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel, ultimately leading to diminished transepithelial anion secretion and mucociliary clearance. CFTR correctors are therapeutics that restore the folding/trafficking of mutated CFTR to the plasma membrane. The large-conductance calcium-activated potassium channel (BK Ca , K Ca 1.1) is also critical for maintaining lung airway surface liquid (ASL) volume. Here, we show that the class 2 (C2) CFTR corrector VX-445 (elexacaftor) induces K + secretion across WT and F508del CFTR primary human bronchial epithelial cells (HBEs), which was entirely inhibited by the BK Ca antagonist paxilline. Similar results were observed with VX-121, a corrector under clinical evaluation. Whole-cell patch-clamp recordings verified that CFTR correctors potentiated BK Ca activity from both primary HBEs and HEK cells stably expressing the α subunit (HEK-BK cells). Furthermore, excised patch-clamp recordings from HEK-BK cells verified direct action on the channel and demonstrated a significant increase in open probability. In mouse mesenteric artery, VX-445 induced a paxilline-sensitive vasorelaxation of preconstricted arteries. VX-445 also reduced firing frequency in primary rat hippocampal and cortical neurons. We raise the possibilities that C2 CFTR correctors gain additional clinical benefit by activation of BK Ca in the lung yet may lead to adverse events through BK Ca activation elsewhere.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic Fibrosis Transmembrane Conductance RegulatorLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsBenzodioxolesHumansAnimalsMiceHEK293 CellsRatsAminopyridinesCystic FibrosisBronchiEpithelial CellsAcetamidesIndolesTriphenylmethyl Compounds

Stichwörter der Autor:innen

Chloride channelsDrug therapyPotassium channelsTherapeutics

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsBenzodioxolesCFTR protein, humanKCNMA1 protein, humanAminopyridineslumacaftorpaxillineBKCa protein, mousesenicapoc

Autor:innen und Institutionen

  • Department of Cell Biology.
  • Department of Pharmacology and Chemical Biology, and.
  • Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Physiology and Biophysics, Chicago Medical School, North Chicago, Illinois, USA.
  • Department of Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NIA NIH HHS
  • Cystic Fibrosis Foundation
  • NIH

Zitieren

APA

Kolski-Andreaco, A., Taiclet, S., Myerburg, M. M., Sembrat, J., Bridges, R. J., Straub, A. C., Wills, Z. P., Butterworth, M. B., & Devor, D. C. (2024). Potentiation of BKCa channels by cystic fibrosis transmembrane conductance regulator correctors VX-445 and VX-121. Journal of Clinical Investigation. https://doi.org/10.1172/jci176328

Vancouver

Kolski-Andreaco A, Taiclet S, Myerburg MM, Sembrat J, Bridges RJ, Straub AC, et al. Potentiation of BKCa channels by cystic fibrosis transmembrane conductance regulator correctors VX-445 and VX-121. Journal of Clinical Investigation. 2024. doi:10.1172/jci176328

BibTeX
@article{KolskiAndreaco2024,
  author = {Kolski-Andreaco, Aaron and Taiclet, Stefanie and Myerburg, Michael M and Sembrat, John and Bridges, Robert J and Straub, Adam C and Wills, Zachary P and Butterworth, Michael B and Devor, Daniel C},
  title = {Potentiation of BKCa channels by cystic fibrosis transmembrane conductance regulator correctors VX-445 and VX-121},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci176328}
}
Kostenlos starten →